A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/135 (2006.01) A61K 9/00 (2006.01) A61K 31/4706 (2006.01) A61K 9/14 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01)
Patent
CA 2473991
The present invention relates to controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor, (CETPI) methods of using and methods of making same. In particular, it relates to a controlled release form of the CETPI [2R,4S] 4-[(3,5-bis-trifluoromethyl-benzyl)- methodyycarbonyl-amino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1- carboxylic acid ethyl ester.
L'invention porte sur une forme posologique à libération contrôlée d'une protéine inhibant le transfert du cholestéryle ester (CEPTI), sur ses procédés de fabrication et d'utilisation, et en particulier sur une forme à libération contrôlée de CEPTI, ester de l'acide [2R,4S] 4-[(3,5-bis-trifluorométhyl-benzyl)-méthodyycarbonyl-amino]-2-éthyl-6-trifluorométhyl-3,4-dihydro-2H-quinoline-1-carboxylique.
Appel Leah Elizabeth
Curatolo William John
Sutton Steven Charles
Bend Research Inc.
Pfizer Products Inc.
Sim & Mcburney
LandOfFree
Controlled release pharmaceutical dosage forms of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release pharmaceutical dosage forms of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release pharmaceutical dosage forms of a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2027718